• Info
  • Insider Ownership

Insider Trading & Ownership of CARL L. GORDON

Location
New York, NY
Summary
The estimated net worth of CARL L. GORDON is at least $33.6M dollars as of 18 Dec 2025. CARL L. GORDON is the Director of Venetian-1 Acquisition Corp. and owns shares of Lomond Therapeutics Holdings, Inc. stock worth about $10.7M. CARL L. GORDON is the Director, 10%+ Owner of MBX Biosciences, Inc. and owns shares of MBX Biosciences, Inc. (MBX) stock worth about $8.11M. CARL L. GORDON is the Director, 10%+ Owner of Terns Pharmaceuticals, Inc. and owns shares of Terns Pharmaceuticals, Inc. (TERN) stock worth about $7.56M. CARL L. GORDON is the Director, 10%+ Owner of ArriVent Biopharma, Inc. and owns shares of ArriVent BioPharma, Inc. (AVBP) stock worth about $5.52M. CARL L. GORDON is the Director, 10%+ Owner of Adicet Bio, Inc. and owns shares of Adicet Bio, Inc. (ACET) stock worth about $942K. CARL L. GORDON is the Director of Keros Therapeutics, Inc. and owns shares of Keros Therapeutics, Inc. (KROS) stock worth about $800K.
Signature
/s/ Carl L. Gordon
All Insider Reports
All Insider Reports

Notify me when CARL L. GORDON files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of CARL L. GORDON

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NONE Lomond Therapeutics Holdings, Inc. Director $10.7M 01 Nov 2024
MBX MBX Biosciences, Inc. Director, 10%+ Owner $8.11M +$2.02M +33.2% 14 Feb 2025
TERN Terns Pharmaceuticals, Inc. Director, 10%+ Owner $7.56M 15 Jul 2024
AVBP ArriVent BioPharma, Inc. Director, 10%+ Owner $5.52M 30 Jan 2024
ACET Adicet Bio, Inc. Director, 10%+ Owner $942K 21 Aug 2024
KROS Keros Therapeutics, Inc. Director $800K 21 Nov 2025
CMPX Compass Therapeutics, Inc. Director, 10%+ Owner $0 -$5.68M -100% 09 Apr 2025
KNTE Kinnate Biopharma Inc. Director, 10%+ Owner $0 03 Apr 2024
THRX Theseus Pharmaceuticals, Inc. Director, 10%+ Owner $0 14 Feb 2024
IRON Disc Medicine, Inc. Director, 10%+ Owner 04 Oct 2021
ORIC Oric Pharmaceuticals, Inc. Director, 10%+ Owner 16 Jun 2021

Insider Transactions Reported by CARL L. GORDON:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.